InsiderTrades.com logo

Matthew Kwietniak Biography and Net Worth

Chief Commercial Officer of Avid Bioservices
  • LinkedIn
  • Phone
  • Email
  • Website


Matthew Kwietniak currently serves as Chief Commercial Officer of Avid Bioservices and has over 30 years of sales experience spanning CDMO offerings, clinical development services and scientific products. Most recently he served as head of drug product sales for the Americas within the pharma services group at Thermo Fisher Scientific. In this role, Mr. Kwietniak is credited with record sales growth and consistent overachievement of quarterly and annual goals during his tenure and leadership. He also spent over a decade as a senior sales executive in the clinical development services business at Covance, Inc., a division of LabCorp. Throughout his time with Covance, Mr. Kwietniak held multiple escalating sales leadership roles, culminating in a three-year tenure as executive director of sales in the clinical development services division. During which time, he expanded and managed a U.S. commercial team of business development directors that included the signing of several large Phase III contracts. In his leadership career, he has been responsible for growing and supporting sales teams generating in excess of $1 billion annually.  Mr. Kwietniak has also achieved success in key sales manager and sales representative positions for VWR International (now Avantor).

Mr. Kwietniak is an accomplished senior global sales executive with a proven track record of driving revenue growth and delivering sustainable results through the building and management of successful sales teams, as well as the establishment and expansion of key client relationships.

What is Matthew R. Kwietniak's net worth?

The estimated net worth of Matthew R. Kwietniak is at least $317,460.47 as of October 14th, 2024. Mr. Kwietniak owns 25,407 shares of Avid Bioservices stock worth more than $317,460 as of May 12th. This net worth evaluation does not reflect any other investments that Mr. Kwietniak may own. Additionally, Mr. Kwietniak receives an annual salary of $409,430.00 as Chief Commercial Officer at Avid Bioservices. Learn More about Matthew R. Kwietniak's net worth.

How old is Matthew R. Kwietniak?

Mr. Kwietniak is currently 55 years old. There are 4 older executives and no younger executives at Avid Bioservices. The oldest executive at Avid Bioservices is Mr. Mark R. Ziebell J.D., VP, General Counsel & Corporate Secretary, who is 60 years old. Learn More on Matthew R. Kwietniak's age.

What is Matthew R. Kwietniak's salary?

As the Chief Commercial Officer of Avid Bioservices, Inc., Mr. Kwietniak earns $409,430.00 per year. There are 4 executives that earn more than Mr. Kwietniak. The highest earning executive at Avid Bioservices is Mr. Nicholas Stewart Green B.Sc., MBA, President, CEO & Director, who commands a salary of $699,010.00 per year. Learn More on Matthew R. Kwietniak's salary.

How do I contact Matthew R. Kwietniak?

The corporate mailing address for Mr. Kwietniak and other Avid Bioservices executives is 2642 Michelle Drive Suite 200, TUSTIN CA, 92780. Avid Bioservices can also be reached via phone at (714) 508-6100 and via email at sdiaz@vidasp.com. Learn More on Matthew R. Kwietniak's contact information.

Has Matthew R. Kwietniak been buying or selling shares of Avid Bioservices?

Matthew R. Kwietniak has not been actively trading shares of Avid Bioservices during the last quarter. Most recently, Matthew R. Kwietniak sold 119 shares of the business's stock in a transaction on Monday, October 14th. The shares were sold at an average price of $10.15, for a transaction totalling $1,207.85. Following the completion of the sale, the insider now directly owns 25,407 shares of the company's stock, valued at $257,881.05. Learn More on Matthew R. Kwietniak's trading history.

Who are Avid Bioservices' active insiders?

Avid Bioservices' insider roster includes Mark Bamforth (Director), Nicholas Green (CEO), Richard Hancock (Director), Daniel Hart (CFO), Matthew Kwietniak (Chief Commercial Officer), Richard Richieri (CGMP Operations), and Mark Ziebell (General Counsel). Learn More on Avid Bioservices' active insiders.

Are insiders buying or selling shares of Avid Bioservices?

In the last twelve months, insiders at the biopharmaceutical company sold shares 13 times. They sold a total of 378,389 shares worth more than $4,552,451.43. The most recent insider tranaction occured on January, 10th when insider Richard A Richieri sold 2,283 shares worth more than $28,240.71. Insiders at Avid Bioservices own 3.1% of the company. Learn More about insider trades at Avid Bioservices.

Information on this page was last updated on 1/10/2025.

Matthew R. Kwietniak Insider Trading History at Avid Bioservices

See Full Table

Matthew R. Kwietniak Buying and Selling Activity at Avid Bioservices

This chart shows Matthew R Kwietniak's buying and selling at Avid Bioservices by year and by quarter.

Skip ChartChart Data in Insider Trading History Table
2022202320242025$0bought$0soldQ2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4Q1Q2-$2k$0$2kTotal Insider BuyingTotal Insider Selling

Avid Bioservices Company Overview

Avid Bioservices logo
Avid Bioservices, Inc. operates as a contract development and manufacturing organization for the biotechnology and biopharmaceutical industries in the United States. It provides process development and current good manufacturing practice clinical and commercial manufacturing services of biologics, including clinical and commercial drug substance manufacturing, bulk packaging, release and stability testing, regulatory submission and support, upstream and downstream development and optimization, analytical methods development, cell line development, testing, and characterization services. The company was formerly known as Peregrine Pharmaceuticals, Inc. and changed its name to Avid Bioservices, Inc. in January 2018. Avid Bioservices, Inc. was incorporated in 1981 and is based in Tustin, California.
Read More

Today's Range

Now: $12.50
Low: $12.47
High: $12.51

50 Day Range

MA: $12.50
Low: $12.50
High: $12.50

2 Week Range

Now: $12.50
Low: $6.53
High: $12.51

Volume

3,067,700 shs

Average Volume

1,351,856 shs

Market Capitalization

$799.18 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.39